These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19401687)

  • 1. Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer.
    Barboro P; Repaci E; Rubagotti A; Salvi S; Boccardo S; Spina B; Truini M; Introini C; Puppo P; Ferrari N; Carmignani G; Boccardo F; Balbi C
    Br J Cancer; 2009 May; 100(10):1608-16. PubMed ID: 19401687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer: prognostic significance of the association of heterogeneous nuclear ribonucleoprotein K and androgen receptor expression.
    Barboro P; Salvi S; Rubagotti A; Boccardo S; Spina B; Truini M; Carmignani G; Introini C; Ferrari N; Boccardo F; Balbi C
    Int J Oncol; 2014 May; 44(5):1589-98. PubMed ID: 24626777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor activity is affected by both nuclear matrix localization and the phosphorylation status of the heterogeneous nuclear ribonucleoprotein K in anti-androgen-treated LNCaP cells.
    Barboro P; Borzì L; Repaci E; Ferrari N; Balbi C
    PLoS One; 2013; 8(11):e79212. PubMed ID: 24236111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer.
    Capaia M; Granata I; Guarracino M; Petretto A; Inglese E; Cattrini C; Ferrari N; Boccardo F; Barboro P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines.
    Barboro P; Repaci E; Ferrari N; Rubagotti A; Boccardo F; Balbi C
    Prostate; 2011 Sep; 71(13):1466-79. PubMed ID: 21321982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma.
    Chen LC; Hsueh C; Tsang NM; Liang Y; Chang KP; Hao SP; Yu JS; Chang YS
    Clin Cancer Res; 2008 Jun; 14(12):3807-13. PubMed ID: 18559600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells.
    Otoshi T; Tanaka T; Morimoto K; Nakatani T
    PLoS One; 2015; 10(12):e0145769. PubMed ID: 26713736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher expression of the heterogeneous nuclear ribonucleoprotein k in melanoma.
    Wen F; Shen A; Shanas R; Bhattacharyya A; Lian F; Hostetter G; Shi J
    Ann Surg Oncol; 2010 Oct; 17(10):2619-27. PubMed ID: 20499280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.
    Phoomak C; Park D; Silsirivanit A; Sawanyawisuth K; Vaeteewoottacharn K; Detarya M; Wongkham C; Lebrilla CB; Wongkham S
    Mol Oncol; 2019 Feb; 13(2):338-357. PubMed ID: 30444036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation.
    Mukhopadhyay NK; Kim J; Cinar B; Ramachandran A; Hager MH; Di Vizio D; Adam RM; Rubin MA; Raychaudhuri P; De Benedetti A; Freeman MR
    Cancer Res; 2009 Mar; 69(6):2210-8. PubMed ID: 19258514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of multiple alternative forms of heterogeneous nuclear ribonucleoprotein K by phosphate-affinity electrophoresis.
    Kimura Y; Nagata K; Suzuki N; Yokoyama R; Yamanaka Y; Kitamura H; Hirano H; Ohara O
    Proteomics; 2010 Nov; 10(21):3884-95. PubMed ID: 20960454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous nuclear ribonucleoprotein K is overexpressed and associated with poor prognosis in gastric cancer.
    Yang R; Zeng Y; Xu H; Chen Z; Xiang M; Fu Y; Yin Y; Zhong J; Zeng M; Wang P; You Q; Zeng X
    Oncol Rep; 2016 Aug; 36(2):929-35. PubMed ID: 27278897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer.
    Carpenter B; McKay M; Dundas SR; Lawrie LC; Telfer C; Murray GI
    Br J Cancer; 2006 Oct; 95(7):921-7. PubMed ID: 16953238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma.
    Szczyrba J; Nolte E; Hart M; Döll C; Wach S; Taubert H; Keck B; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
    Int J Cancer; 2013 Feb; 132(4):775-84. PubMed ID: 22815235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.
    Zhou R; Shanas R; Nelson MA; Bhattacharyya A; Shi J
    Int J Cancer; 2010 Jan; 126(2):395-404. PubMed ID: 19609950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis.
    Zhou X; Li Q; He J; Zhong L; Shu F; Xing R; Lv D; Lei B; Wan B; Yang Y; Wu H; Mao X; Zou Y
    Oncotarget; 2017 Mar; 8(12):19342-19353. PubMed ID: 28038443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients.
    Chen LC; Chung IC; Hsueh C; Tsang NM; Chi LM; Liang Y; Chen CC; Wang LJ; Chang YS
    Cell Death Differ; 2010 Sep; 17(9):1463-73. PubMed ID: 20224598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression.
    Barboro P; Ferrari N; Balbi C
    Cancer Lett; 2014 Oct; 352(2):152-9. PubMed ID: 25016060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells.
    Chen LC; Liu HP; Li HP; Hsueh C; Yu JS; Liang CL; Chang YS
    Oncogene; 2009 Apr; 28(17):1904-15. PubMed ID: 19330019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous nuclear ribonucleoprotein K is overexpressed and contributes to radioresistance irrespective of HPV status in head and neck squamous cell carcinoma.
    Kähler J; Hafner S; Popp T; Hermann C; Rump A; Port M; Steinestel K; Eder S
    Int J Mol Med; 2020 Nov; 46(5):1733-1742. PubMed ID: 32901844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.